Question special
Lead Moderator

I want to thank all of the authors and experts for your participation in this discussion. There have been many insightful and stimulating comments throughout.

I'd like to close off by asking what the greatest challenges have been with ClinGen? What are the greatest anticipated challenges for the road ahead?